Clinical Trial Update: Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated autologous laboratory-treated T cells and Aldesleukin after Cyclophosphamide in patients with Stage IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Aldesleukin (interleukin-2)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Laboratory-Treated T Cells (adoptive T cell therapy)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 1, Phase 2 | Status: COMPLETED